Search Results - "Opazo-Ríos, Lucas"

SOCS1 Mimetic Peptide Enhances Empagliflozin Improvement on Kidney Damage in the Type 2 Diabetes Mouse Model BTBR ob/ob.

Authors: Aguilar-Cartes, Marcelo Opazo-Ríos, Lucas Droguett, Alejandra et al.

Source: International Journal of Molecular Sciences. Mar2026, Vol. 27 Issue 5, p2466. 14p.

Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.

Authors: Soto-Catalán, Manuel Opazo-Ríos, Lucas Quiceno, Hernán et al.

Source: International Journal of Molecular Sciences. Mar2024, Vol. 25 Issue 5, p2961. 14p.

The Role of miR-802 in Diabetic Kidney Disease: Diagnostic and Therapeutic Insights.

Authors: Tejera-Muñoz, Antonio Marchant, Vanessa Tejedor-Santamaría, Lucía et al.

Source: International Journal of Molecular Sciences. Jun2025, Vol. 26 Issue 12, p5474. 12p.

Meta-Inflammation and De Novo Lipogenesis Markers Are Involved in Metabolic Associated Fatty Liver Disease Progression in BTBR ob/ob Mice.

Authors: Opazo-Ríos, Lucas Soto-Catalán, Manuel Lázaro, Iolanda et al.

Source: International Journal of Molecular Sciences. Apr2022, Vol. 23 Issue 7, p3965-N.PAG. 18p.

Targeting NF-κB by the Cell-Permeable NEMO-Binding Domain Peptide Improves Albuminuria and Renal Lesions in an Experimental Model of Type 2 Diabetic Nephropathy.

Authors: Opazo-Ríos, Lucas Plaza, Anita Sánchez Matus, Yenniffer et al.

Source: International Journal of Molecular Sciences. Jun2020, Vol. 21 Issue 12, p4225. 1p.

Lipotoxicity and Diabetic Nephropathy: Novel Mechanistic Insights and Therapeutic Opportunities.

Authors: Opazo-Ríos, Lucas Mas, Sebastián Marín-Royo, Gema et al.

Source: International Journal of Molecular Sciences. Apr2020, Vol. 21 Issue 7, p2632. 1p. 3 Diagrams, 2 Charts.

Pathogenic Pathways and Therapeutic Approaches Targeting Inflammation in Diabetic Nephropathy.

Authors: Rayego-Mateos, Sandra Morgado-Pascual, José Luis Opazo-Ríos, Lucas et al.

Source: International Journal of Molecular Sciences. Jun2020, Vol. 21 Issue 11, p3798-3798. 1p.

The Coming Age of Flavonoids in the Treatment of Diabetic Complications.

Authors: Caro-Ordieres, Teresa Marín-Royo, Gema Opazo-Ríos, Lucas et al.

Source: Journal of Clinical Medicine. Feb2020, Vol. 9 Issue 2, p346. 1p.

Could IL-17A Be a Novel Therapeutic Target in Diabetic Nephropathy?

Authors: Lavoz, Carolina Rayego-Mateos, Sandra Orejudo, Macarena et al.

Source: Journal of Clinical Medicine. Jan2020, Vol. 9 Issue 1, p272-272. 1p.

Toll-Like Receptors in Acute Kidney Injury.

Authors: Vázquez-Carballo, Cristina Guerrero-Hue, Melania García-Caballero, Cristina et al.

Source: International Journal of Molecular Sciences. Jan2021, Vol. 22 Issue 2, p816-816. 1p.